Document is current
Any future updates will be listed below
-
Authors
Tao, Julia
Murray, Jason
Tu, Hsin-Fang
Fan, Darrell
Tsai, Ya-Chea
Hu, Ming-Hung
Wu, Annie A.
Xing, Deyin
Hung, Chien-Fu
Wu, T.-C. https://orcid.org/0000-0003-1623-4584
-
Funding
Funding for this research was provided by:
National Cancer Institute (P50CA098252, R01CA237067, R21DE029910-01, R21CA256020, 1R21CA234516-01A1)
- License Information
-
More Information
Article History
Received: 2 October 2024
Accepted: 7 June 2025
First Online: 18 June 2025
Declarations
:
: Animal procedures were approved by the Johns Hopkins Institutional Animal Care and Use Committee, and all mice were managed in accordance to protocols.
: Not applicable.
: TC.W. is a co-founder of and have an equity ownership interest in Papivax LLC. Also, he owns Papivax Biotech Inc. stock options and is a member of Papivax Biotech Inc.’s Scientific Advisory Board. Additionally, under a licensing agreement between Papivax Biotech Inc. and the Johns Hopkins University, TC.W. and CF.H. are entitled to royalties on an invention described in this article. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. Other co-authors declare no conflicts of interest.
